RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

Target & Classification

Virus:

HPVHuman papillomavirus

Type:

Virus-like particle vaccine

Diseases:

Atypical Squamous Cells of Undetermined Significance; Human Papilloma Virus Infection; Aerodigestive Precancerous Lesions and Malignancies; Respiratory Papillomatosis; Human Papillomavirus Infection;; Anal Intraepithelial Neoplasia; HIV; Solid Tumors; Squamous Cell Carcinoma of the Oropharynx; HPV16 Positive; Cervical Cancer; Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma of the Head and Neck; Human Papillomavirus-16 Positive; Human Papillomavirus-18 Positive

Max Phase:

Phase 3

Clinical Development

Phase 1

Phase 2

Phase 3

Approved

Clinical Trials12

NCT ID	Phase	Disease / Condition
NCT00426361	Phase 3	Atypical Squamous Cells of Undetermined Significance
NCT00231413	Phase 2	Human Papilloma Virus Infection
NCT00120848	Phase 2	Aerodigestive Precancerous Lesions and Malignancies
NCT00306241	Phase 3	Respiratory Papillomatosis
NCT00572000	—	Human Papillomavirus Infection;
NCT00290277	Phase 3	Anal Intraepithelial Neoplasia; HIV
NCT00169494	Phase 3	Solid Tumors
NCT00196924	Phase 3	Squamous Cell Carcinoma of the Oropharynx; HPV16 Positive
NCT01263327	Phase 1	Cervical Cancer
NCT01548118	Phase 1	Squamous Cell Carcinoma of the Oropharynx
NCT02740777	Phase 2	Squamous Cell Carcinoma of the Head and Neck
NCT02733068	Phase 3	Human Papillomavirus-16 Positive; Human Papillomavirus-18 Positive